INSM.....may not be as bad as first thought....here is something from another thread.....
IPLEX can still be given to shortstature patients who specifically request IPLEX at 40% royalty. Yes the royalty is high, but it's not exactly off the market.
IPLEX can be given to ALS, and other non-TRCA indications at 4% royalty.